FOCUS trial: results, potentialities and limits

Saba, Luca
First
;Balestrieri, Antonella;Serra, Alessandra;Politi, Carola;Murgia, Alessandro;Mannelli, Lorenzo
2019-01-01

Abstract

In January 2019 Lancet has published the paper “Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial” (1). The main purpose of this prospective trial was to asses if fluoxetine [a selective serotonin reuptake inhibitor (SSRI) drug] could improve recovery after stroke.
2019
Inglese
ANNALS OF TRANSLATIONAL MEDICINE
7
Suppl 3
S152
5
WOS:000483693200078
31576359
Esperti anonimi
internazionale
scientifica
postischemic brain; reuptake inhibitor; stroke; fluoxetine
sì
Saba, Luca; Balestrieri, Antonella; Serra, Alessandra; Garau, Raimondo; Politi, Carola; Lucatelli, Pierleone; Murgia, Alessandro; Suri, Jasjit S; Mannelli, Lorenzo
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
9
reserved
Files in This Item:
File Size Format  
atm-07-S3-S152(1).pdf

Solo gestori archivio

Size 166.12 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
166.12 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie